←
Oncotarget Journal567 posts
Oncotarget Journal avatar

Oncotarget Journal

@OncotargetJrnl

For the latest news and updates from Oncotarget, please follow us @Oncotarget.

◷ Joined December 2019
Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Nov 16

📈 #TrendingWithImpact: "Assessment of genomic instability and homologous recombination repair in ovarian cancer using the Oncomine Comprehensive Assay Plus" #PressRelease ⬇️ bit.ly/48iEBeb #Cancer #OvarianCancer #DNARepair #Research #OA #Publishing #Press #Oncotarget

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Nov 10

🔆 #PaperSpotlight: The #Research paper, "Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5," was published in Volume 17. #PressRelease ⬇️ bit.ly/4kGW8Uy #Cancer #ColorectalCancer #OA #MedEd #Publishing #Oncotarget

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Nov 4

📈 #TrendingWithImpact: The #Research paper, "Survival factors in lung cancer patients with mutations in the PROS1, SERPINC1, F2, and F5 genes," was published in Volume 17. #PressRelease ⬇️ bit.ly/4zxcRhU #Cancer #LungCancer #Thrombophilia #OA #PeerReviewed #Oncotarget

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Oct 26

🔆 #PaperSpotlight: Case Report: "WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer" #PressRelease ⬇️ bit.ly/4dZGy2g #Cancer #ColonCancer #Oncology #OA #PeerReviewed #Publishing #Oncotarget

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Oct 22

📈 #TrendingWithImpact: "Case Report WIN-MTB-2024001 – WIN International Molecular Tumor Board: A 55-year-old male with glioblastoma exhibiting amplifications in MDM2 and EGFR" #PressRelease ⬇️ bit.ly/4iboH9E #Cancer #Glioblastoma #CaseReport #OA #Oncotarget #Press

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Oct 14

📈 #TrendingWithImpact: The #Research paper "Integrative pan-cancer analysis of AKT1 and structure-based drug design by buckwheat derived compounds" was recently published in Volume 17. #PressRelease ⬇️ bit.ly/4ewJfZf #Cancer #Buckwheat #OA #Publishing #Oncotarget

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Sep 28

🔆 #PaperSpotlight: The #Editorial, "Gut feeling: Microbes at the heart of cancer therapy," was recently published in Volume 17. #PressRelease ⬇️ oncotarget.net/2026/09/28/gu… #Cancer #GutMicrobiome #Immunotherapy #Oncology #PeerReviewed #Journal #MedEd #Publishing #Oncotarget #Press

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Sep 17

📈 #TrendingWithImpact: The #Commentary, "Are both COVID-19 and COVID-19 vaccines associated with cancer?," was recently published in Volume 17. #PressRelease ⬇️ oncotarget.net/2026/09/17/co… #Cancer #Research #COVID19 #Vaccines #OpenAccess #PeerReviewed #Journal #Publishing #MedEd

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Sep 9

📈 #TrendingWithImpact: The #Review, titled "Re-expression of MHC-I to treat CNS cancers," was recently published in Volume 17. #PressRelease ⬇️ bit.ly/4hj9NyY #Cancer #BrainCancer #Glioblastoma #Oncology #Oncotarget #OA #PeerReviewed #Publishing #Journal #MedEd

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Sep 1

📈 #TrendingWithImpact: "Emerging biomedical imaging applications of tumor-derived extracellular vesicles for premetastatic niche detection: Biological rationale, engineering strategies, and translational challenges" #PressRelease ⬇️ bit.ly/4qREYET #Cancer #Review #OA

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Aug 31

🔆 #PaperSpotlight: The #Editorial, titled "Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future perspectives," was recently published in Volume 17. #PressRelease ⬇️ bit.ly/3UwkntC #Cancer #Lymphocytes #Immunotherapy #OA

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Aug 28

🔆 #PaperSpotlight: A new #Research paper, titled "Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine," was recently published in Volume 17. #PressRelease ⬇️ bit.ly/3V0k1eR #Cancer #KRAS #OA #PeerReviewed #Publishing

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Aug 25

📈 #TrendingWithImpact: New Precision Oncology paper: “Systematic methodological flaws in DNA contamination assessment of mRNA vaccines: A critical analysis of Achs et al. (2025)” #Published in Volume 17. #PressRelease ⬇️ bit.ly/3Uy5xTl #Cancer #Vaccines #Research #DNA

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Aug 10

📈 #TrendingWithImpact: The #Research paper, titled "Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers," was recently #Published in Volume 17. #PressRelease ⬇️ bit.ly/4g4bL4q #Cancer #EwingSarcoma #OA

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Jul 22

📈 #TrendingWithImpact: A new #PrecisionOncology paper was #Published in Volume 17, titled "WIN-MTB-2024017 – WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers." #PressRelease ⬇️ oncotarget.net/2026/07/22/in… #Cancer #Research #OA #Press

Oncotarget avatar
⟳ Oncotarget Journal retweeted
Oncotarget@Oncotarget·Jul 6

📈 #TrendingWithImpact: This #CaseReport was #Published in Volume 17, titled "Renal oncocytoma: Α case report and literature review." #PressRelease ⬇️ oncotarget.net/2026/07/06/ra… #Oncology #Kidney #RenalOncocytoma #Research #OpenAccess #OpenScience #PeerReview #Journal